title: [Therapy of Presumed Ocular Histoplasmosis Syndrome (POHS) with Bevacizumab].
authors.affiliation: Klinik für Augenheilkunde, Universitätsklinikum Jena.
authors.forename: K
authors.initials: K
authors.lastname: Wildner
authors.affiliation: Klinik für Augenheilkunde, Universitätsklinikum Jena.
authors.forename: E
authors.initials: E
authors.lastname: Königsdörffer
authors.affiliation: Klinik für Augenheilkunde, Universitätsklinikum Jena.
authors.forename: U
authors.initials: U
authors.lastname: Voigt
authors.affiliation: Klinik für Augenheilkunde, Universitätsklinikum Jena.
authors.forename: R
authors.initials: R
authors.lastname: Augsten
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000068258:Bevacizumab / Q000008:administration & dosage*; D020256:Choroidal Neovascularization / Q000175:diagnosis* / Q000188:drug therapy*; D015821:Eye Infections, Fungal / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D006660:Histoplasmosis / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D013577:Syndrome; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab